克服质母细胞瘤中的障碍:CAR T细胞免疫疗法的潜力
Muhammad Ijaz1, Qingqin Tan2, Yuqian Yan1
1School of Science, Shenzhen Key Laboratory of Advanced Functional Carbon Materials Research and Comprehensive Application, Harbin Institute of Technology, Shenzhen-518055, China.
Theranostics
|June 30, 2025
概括
化学抗原受体 (CAR) T 细胞疗法对质母细胞瘤 (GBM) 有前途. 克服脑瘤微环境中的挑战是开发有效的CAR T细胞治疗GBM的关键.
科学领域:
- 神经瘤学神经瘤学
- 免疫治疗是一种免疫疗法.
- 生物技术是生物技术.
背景情况:
- 质母细胞瘤 (GBM) 是一种具有不良预后的侵袭性脑瘤.
- 卡特-T细胞免疫疗法是一种有前途的癌症治疗方法,但在GBM方面面临挑战.
研究的目的:
- 审查质母细胞瘤中CAR T细胞治疗的挑战.
- 探索创新策略,以提高在GBM中CAR T细胞治疗的疗效.
主要方法:
- 关于针对GBM的CAR T细胞疗法的当前文献的综述.
- 分析包括免疫抑制,抗原异质性和血脑屏障在内的挑战.
- 探索CAR T细胞工程和管理方面的进步.
主要成果:
- 在GBM瘤微环境中,CAR T细胞治疗面临着重大障碍.
- 在CAR T细胞工程,向输送和组合疗法方面取得了进展.
- 人工智能驱动的方法提高了目标识别和治疗定制.
结论:
- 克服GBM特定的挑战对于成功的CAR T细胞免疫疗法至关重要.
- 创新策略和人工智能集成有可能改善GBM治疗结果.
- 需要进一步的研究,以加快CAR T细胞治疗质母细胞瘤的临床转化.
更多相关视频
12:52Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
Published on: November 28, 2015
16.0K
11:15Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
Published on: September 1, 2018
8.0K
相关概念视频
01:27Tumor Immunotherapy
667
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
667
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K